Senior Director, Pipeline Market Access Strategy - Immunology

AbbVie

Where
Hybrid in Mettawa, IL, United States

Posted 9 days ago· Checked live at AbbVie 1 hour ago

Live.Open on the employer's own site.

See how you score for this job

One sentence and your resume. We score it against what AbbVie asks for, line by line.

See my score
Is this job still open?
Yes. We checked it live on AbbVie's own hiring page 1 hour ago.
What is the job?
Job Description The Senior Director, Pipeline Market Access Strategy (PMAX) is a newly created role responsible for leading and inspiring the end-to-end global market access strategy for pipeline assets within their assigned Business Unit.
What does it pay?
The posting doesn't say.
Our verdict
Live. Open on the employer's own site.

What the job is

Job Description

The Senior Director, Pipeline Market Access Strategy (PMAX) is a newly created role responsible for leading and inspiring the end-to-end global market access strategy for pipeline assets within their assigned Business Unit.

Experience

  • A minimum of 12–15 years of progressive, senior-level experience in market access, pricing, reimbursement, HEOR, or a closely related pharmaceutical/biopharmaceutical function — with a substantial portion of that experience focused on pipeline and pre-launch strategy.
  • Demonstrated expertise in global market access, including a deep working knowledge of HTA processes, payer evidence requirements, pricing and reimbursement frameworks, and access decision-making dynamics across major international markets (US, EU5, Japan, and additional key markets).
  • Proven experience shaping clinical development strategy from a market access and outcomes evidence perspective — including direct experience contributing to clinical trial design, endpoint selection, and Integrated Evidence Plan development in collaboration with R&D teams.
  • Strong track record of leading and developing high-performing teams in a matrixed, multinational environment, with demonstrated ability to manage direct reports and influence cross-functional partners without direct authority.
  • Experience supporting Business Development activities including asset due diligence, licensing evaluations, and access-based valuation assessments is highly preferred.
  • Comfortable operating at the senior leadership level, with demonstrated ability to communicate complex access strategy to executive audiences and influence enterprise-level pipeline investment decisions.
  • Experience across multiple therapeutic areas (e.g., Oncology, Immunology, Neuroscience) is an asset, though deep expertise in at least one is required.